Christopher McNulty
Director of Finance/CFO presso Ring Therapeutics, Inc.
Patrimonio netto: 743 $ in data 31/03/2024
Profilo
Christopher McNulty is currently the Chief Financial Officer & Head-Corporate Strategy at Ring Therapeutics, Inc. He previously worked as the Senior Director-Business Development at Repligen Corp.
from 2010 to 2013, Associate Director-Business Development at Genzyme Corp.
in 2008-2009, Director-Corporate Development at YourBio Health, Inc. in 2009-2010, and Chief Financial & Accounting Officer at Invivo Therapeutics Holdings Corp.
from 2017 to 2018.
He also held various Principal positions at Ionis Pharmaceuticals, Inc., PTC Therapeutics, Inc., Cereon Genomics LLC, and Hewlett-Packard Laboratories.
McNulty's education includes an undergraduate and graduate degree from Massachusetts Institute of Technology and an MBA degree from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VBI VACCINES, INC.
0.01% | 26/01/2023 | 1 233 ( 0.01% ) | 743 $ | 31/03/2024 |
Posizioni attive di Christopher McNulty
| Società | Posizione | Inizio |
|---|---|---|
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01/05/2023 |
Precedenti posizioni note di Christopher McNulty
| Società | Posizione | Fine |
|---|---|---|
| VBI VACCINES INC. | Director of Finance/CFO | 10/04/2023 |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Director of Finance/CFO | 01/05/2018 |
| REPLIGEN CORPORATION | Corporate Officer/Principal | 01/11/2013 |
YourBio Health, Inc.
 YourBio Health, Inc. Electronic Equipment/InstrumentsElectronic Technology YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA. | Corporate Officer/Principal | 01/04/2010 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/03/2009 |
Formazione di Christopher McNulty
| Massachusetts Institute of Technology | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| PTC THERAPEUTICS, INC. | Health Technology |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| VBI VACCINES INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
YourBio Health, Inc.
YourBio Health, Inc. Electronic Equipment/InstrumentsElectronic Technology YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA. | Electronic Technology |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
| Cereon Genomics LLC | |
| Hewlett-Packard Laboratories | |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher McNulty
